A V S Anil Kumar1, P G Kumar1, Sangeetha Sampath2, V Suhag3. 1. Senior Adviser (Medicine & Nuclear Medicine), Command Hospital (Southern Command), Pune 411040, India. 2. Assistant Professor, Department of Biochemistry, Armed Forces Medical College, Pune 411040, India. 3. Classified Specialist (Radiotherapy), Army Hospital (R&R), New Delhi, India.
Abstract
BACKGROUND: Tumour seeking characteristics of TL-201 have been underutilized. The study was undertaken to evaluate the role of TL-201 scintigraphy in tumour imaging. METHODS: A total of 50 cases were studied over a period of 18 months (13 lymphomas, 11 breast carcinoma, 10 lung cancer, 6 of soft tissue sarcoma, 2 bone tumours and 4 cases each of thyroid and brain tumours). Thallium-201 chloride was injected IV in the dose range of 3-5 mCi. Imaging was done using Siemen's ECAM dual headed gamma camera. Mean tumour to background ratio (T/B ratio) was calculated for all the positive cases. Descriptive statistical analysis was carried out. RESULTS: Findings revealed a sensitivity of 94.12%, specificity 87.5%, PPV 94.12%, NPV 87.50% and accuracy of 92% for TL-201 tumour imaging. The mean T/B ratio for the true positive cases at 10 min and at 3 h was 1.81 and 1.99 respectively, the difference being 0.18 (P value <0.001). Amongst them, the mean T/B ratios for low-grade tumours were 1.45 ± 0.32 at 10 min and 1.63 ± 0.38 after 3 h with difference of 0.176 (P < 0.001). For the high-grade tumours the ratios were 2.08 ± 0.35 and 2.26 ± 0.41 respectively with a difference of 0.186 (P < 0.001). CONCLUSION: Thallium-201 scintigraphy is a useful tumour imaging modality in cases of thyroid, breast, brain, lung, soft tissue and bone tumours and lymphomas. A T/B ratio of 1.63 ± 0.38 in 3 h-delayed imaging is suggestive of low-grade tumours. For high-grade tumours a ratio of 2.26 ± 0.41 should be considered significant.
BACKGROUND:Tumour seeking characteristics of TL-201 have been underutilized. The study was undertaken to evaluate the role of TL-201 scintigraphy in tumour imaging. METHODS: A total of 50 cases were studied over a period of 18 months (13 lymphomas, 11 breast carcinoma, 10 lung cancer, 6 of soft tissue sarcoma, 2 bone tumours and 4 cases each of thyroid and brain tumours). Thallium-201 chloride was injected IV in the dose range of 3-5 mCi. Imaging was done using Siemen's ECAM dual headed gamma camera. Mean tumour to background ratio (T/B ratio) was calculated for all the positive cases. Descriptive statistical analysis was carried out. RESULTS: Findings revealed a sensitivity of 94.12%, specificity 87.5%, PPV 94.12%, NPV 87.50% and accuracy of 92% for TL-201 tumour imaging. The mean T/B ratio for the true positive cases at 10 min and at 3 h was 1.81 and 1.99 respectively, the difference being 0.18 (P value <0.001). Amongst them, the mean T/B ratios for low-grade tumours were 1.45 ± 0.32 at 10 min and 1.63 ± 0.38 after 3 h with difference of 0.176 (P < 0.001). For the high-grade tumours the ratios were 2.08 ± 0.35 and 2.26 ± 0.41 respectively with a difference of 0.186 (P < 0.001). CONCLUSION:Thallium-201 scintigraphy is a useful tumour imaging modality in cases of thyroid, breast, brain, lung, soft tissue and bone tumours and lymphomas. A T/B ratio of 1.63 ± 0.38 in 3 h-delayed imaging is suggestive of low-grade tumours. For high-grade tumours a ratio of 2.26 ± 0.41 should be considered significant.
Authors: K T Kim; K L Black; D Marciano; J C Mazziotta; B H Guze; S Grafton; R A Hawkins; D P Becker Journal: J Nucl Med Date: 1990-06 Impact factor: 10.057
Authors: A H Elgazzar; A A Malki; H M Abdel-Dayem; A Mahmoud; A Sahweil; S Razzak; S Jahan; M el-Sayed; Y T Omar Journal: Nucl Med Commun Date: 1989-07 Impact factor: 1.690
Authors: A D Waxman; L Ramanna; L D Memsic; C E Foster; A W Silberman; S H Gleischman; R J Brenner; M B Brachman; C J Kuhar; J Yadegar Journal: J Nucl Med Date: 1993-01 Impact factor: 10.057
Authors: J W Braams; J Pruim; N J Freling; P G Nikkels; J L Roodenburg; G Boering; W Vaalburg; A Vermey Journal: J Nucl Med Date: 1995-02 Impact factor: 10.057
Authors: A C Rebollo; M Torres-Avisbal; J E Espinosa; C Diaz; J A Vallejo; C Pacheco; C Pera; A Mateo Journal: Br J Radiol Date: 1995-10 Impact factor: 3.039